Atrial Fibrillation
Sunday, September 16th, 2012
ScienceDaily (Sep. 7, 2012) — An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050. “One of the biggest misconceptions about atrial […]
Atrial Fibrillation
Sunday, September 16th, 2012
Heartrhythmjournal.com/: 9/3/12 Catheter ablation is an effective treatment for medically refractory, disabling atrial fibrillation (AF). Ablation success may be limited in patients with persistent or long-standing persistent AF. A pericardioscopic, hybrid epicardial-endocardial technique for AF ablation may be a preferred approach for such patients. Limited data are available using such an approach. Methods A cohort of […]
Atrial Fibrillation
Sunday, September 16th, 2012
Content.onlinejacc.org: 9/1/12 The purpose of this study was to assess whether changes of major atrial fibrillation (AF) risk factors and/or intercurrent cardiovascular events could explain the relationship between type 2 diabetes mellitus (T2D) and incident AF. Background Previous studies found an increased risk of incident AF among individuals with T2D, but few, if any, of these studies […]
Atrial Fibrillation
Sunday, September 16th, 2012
Does It Still Matter in Patients With a CHA2DS2-VASc Score of 0 or 1? Sstroke.ahajournals.org: August 7, 2012 Atrial fibrillation (AF) is an independent risk factor for stroke. Recent studies have demonstrated that the CHA2DS2-VASc scheme is useful for selecting patients who are truly at low risk. The goal of the present study was to compare […]
Atrial Fibrillation
Friday, September 7th, 2012
Heart Rhythm Society’s Second Annual “A-Fib Feels Like” Campaign Educates Americans on How to Recognize Warning Signs of Atrial Fibrillation Heart Rhythm Society: WASHINGTON, September 6, 2012 /PRNewswire/ — Adults over the age of 60 are at the greatest risk of atrial fibrillation (AF), a potentially life-threatening heart rhythm disorder. Yet, according to a recent survey conducted […]
Atrial Fibrillation
Friday, September 7th, 2012
New atrial fibrillation motion graphic launches to further patient education American Heart Association: September 05, 2012 DALLAS, TX– Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation and the correlation between this condition and stroke. Atrial fibrillation, or AFib, is a quivering or irregular heartbeat that […]
Atrial Fibrillation
Friday, September 7th, 2012
Stop Afib: By Mellanie True Hills: September 5, 2012 Video Interview with Dr. Randall Wolf Summary: Dr. Randall Wolf discusses the evolution of the mini maze surgical procedure for atrial fibrillation and the importance of a minimalist approach to lesions. Reading and watching time is approximately 12 minutes In this video interview, Dr. Randall Wolf, creator of the […]
Atrial Fibrillation
Friday, September 7th, 2012
American Journal of Cardiology: June 24, 012 Despite a greater burden of traditional risk factors, atrial fibrillation (AF) is less common among blacks than whites for reasons that are unclear. The aim of this study was to examine race- and gender-specific influences of demographic, lifestyle, anthropometric, and medical factors on AF in a large cohort of […]
Atrial Fibrillation
Friday, August 31st, 2012
Medicalxpress.com: August 28, 2012 The findings were presented today at ESC Congress 2012 by Dr Elena Arbelo from Hospital Clínic de Barcelona, Spain, a co-investigator of the study. “Atrial fibrillation is the most frequent heart rhythm disorder and it represents a highly significant burden of disease and expenditure throughout the world,” explained Dr Arbelo. “The currently […]
Atrial Fibrillation
Friday, August 31st, 2012
Aannals.org: August 28, 2012 New oral anticoagulants (NOACs), including direct thrombin inhibitors (DTIs) and factor Xa (FXa) inhibitors, are emerging alternatives for prophylaxis and treatment of atrial fibrillation (AF) and venous thromboembolism (VTE). Purpose: To compare the benefits and harms of NOACs versus warfarin for AF and VTE. Data Sources: MEDLINE, EMBASE, and the Cochrane Database of Systematic […]